Aprazer Healthcare Entekor 1mg

Aprazer Healthcare Entekor 1mg
Aprazer Healthcare Entekor 1mg
Price And Quantity
  • 1
  • Box/Boxes
  • 1200 INR
Product Specifications
  • Pharmaceutical
  • General Drugs
  • Chronic Hepatitis B
  • Suitable For All Ages, Women, Adult, Children, Infants
  • 1 mg
  • Dry Place
    Product Description

    Composition: One tablet consists of an active active ingredient - Entecavir (1 mg.) and additional excipients.


    Packing: It is delivered in a plastic jar, with a total volume of 30 tablets.




    ENTEKOR 1mg is successfully used for the therapy of chronic hepatitis B. A more effective drug, in comparison with interferon, is a new drug formula designed to directly inhibit the protease of the HBV virus.


    The benefits of therapy can be presented in this way:


    ·        safety and high efficiency;

    ·         High rates of absorption;

    ·         minimal, delayed resistance;

    ·         Persistent remission.

    ENTEKOR 1MG suppresses the replica of the HBV virus in all three stages, penetrates into the cells affected by the virus, and prevents the splitting of the protein of the viral particle, thus affecting the process of reproduction of the viral RNA.

    The recommended dose is 1 tablet per day. Take inside on an empty stomach.

    In the presence of pathological processes of the liver or kidneys of various origin, the dosage is selected strictly individually.


    The use of the drug may cause adverse reactions in the body, this is: 

    ·       dizziness;

    ·        a state of lack of sleep;

    ·       general weakness and fatigue;

    ·         pain in the abdominal cavity;

    ·         allergic reactions;

    ·         muscular asthenia;

    ·         labored breathing.

    Entecavir 1mg


    Entekor (Entecavir 1mg refers to new drugs from the group of nucleoside analogues for the treatment of chronic HBV infection. It is a carboxylic analogue of 2'-deoxyguanosine, rapidly transforming into a cell in an active form, suppressing the replication of HBV in all its three stages - initiation, elongation, termination. Conducted studies of the efficacy of  Entecavir in the treatment of patients with chronic hepatitis B showed good tolerability, a high safety profile, a higher efficacy than Lamivudine, and a lack of resistance after 2 years of administration in patients previously untreated with nucleoside analogues. The efficacy of the drug for prescribing patients resistant to Lamivudine was also demonstrated. In all of these cases, Entecavir can be considered the first-line therapy for HBV infection.

    Trade Information
    • Letter of Credit (L/C)
    • 100 Per Week
    • 2-3 Days
    • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
    • All India
    Contact Us

    16/8, Old Rajinder Nagar, New Delhi, Delhi, 110060, India
    Phone :+918037301152